Quarterly report (Form 10-Q)
Bed Bath & Beyond 10-Q for Quarter ended Mar 31, 2026
Filing excerpt
Consolidated cash and cash equivalents decreased from $175.3 million as of December 31, 2025, to $135.8 million as of March 31, 2026, a decrease of $39.5 million, primarily as a result of disbursement for notes receivable of $26.2 million with $20.0 million to TBHC, and net cash outflows from operating activities of $11.8 million.